AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 297: E956-E964, 2009. First published August 11, 2009; doi:10.1152/ajpendo.00058.2009
0193-1849/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/4/E956    most recent
00058.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Mortensen, B.
Right arrow Articles by Wojtaszewski, J. F. P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mortensen, B.
Right arrow Articles by Wojtaszewski, J. F. P.

Genetic and metabolic effects on skeletal muscle AMPK in young and older twins

Brynjulf Mortensen,1,2 Pernille Poulsen,2 Lise Wegner,2 Kirstine L. Stender-Petersen,2 Rasmus Ribel-Madsen,2 Martin Friedrichsen,2 Jesper B. Birk,1 Allan Vaag,2 and Jørgen F. P. Wojtaszewski1

1Molecular Physiology Group, Department of Exercise and Sport Sciences, University of Copenhagen; and 2Steno Diabetes Center, Gentofte, Denmark/

Submitted 29 January 2009 ; accepted in final form 11 August 2009

The protein complex AMP-activated protein kinase (AMPK) is believed to play an important role in the regulation of skeletal muscle glucose and lipid metabolism. Defects in the AMPK system might therefore be an important factor in the pathogenesis of type 2 diabetes. We aimed to identify genetic and environmental mechanisms involved in the regulation of AMPK expression and activity and to examine the association between AMPK protein levels and activity on the one hand, and glucose and fat metabolism on the other. We investigated skeletal muscle biopsies from 100 young and 82 older mono- and dizygotic nondiabetic twins excised during the basal and insulin-stimulated states of a physiological hyperinsulinemic-euglycemic clamp. AMPK{alpha}1, -{alpha}2, and -{gamma}3 mRNA expression was investigated using real-time PCR, and Western blotting was employed to measure protein levels. Multiple regression analyses indicated that skeletal muscle AMPK mRNA and protein expression as well as activity were regulated by sex, age, obesity, and aerobic capacity. Comparison of intraclass correlations on AMPK measurements from mono- and dizygotic twins suggested that skeletal muscle AMPK expression was under minor genetic influence. AMPK{gamma}3 protein expression and activity were negatively related to whole body glucose uptake through the nonoxidative metabolic pathway and positively related to phosphorylation of glycogen synthase. Our results suggest that skeletal muscle AMPK expression is under minor genetic control but regulated by age and sex and associated with obesity and aerobic capacity. Furthermore, our results indicate a role for {gamma}3-containing AMPK complexes in downregulation of insulin-stimulated nonoxidative glucose metabolism possibly through inhibition of glycogen synthase activity.

5'-adenosine monophosphate-activated protein kinase; heritability; glucose metabolism



Address for reprint requests and other correspondence: B. Mortensen, Steno Diabetes Center, Niels Steensens Vej 1, DK-2820 Gentofte, Denmark (E-mail: Brym{at}steno.dk).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.